Recovery

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

AB
AP BiosciencesTaiwan - Taipei
1 program
WHO QualityRights programN/A1 trial
Active Trials
NCT06874439Active Not RecruitingEst. Oct 2027

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
AP BiosciencesWHO QualityRights program

Clinical Trials (1)

NCT06874439AP BiosciencesWHO QualityRights program

An Evaluation of the WHO QUAlityRights Program

Start: Jun 2024Est. completion: Oct 2027
N/AActive Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space